Reciprocal effects of α-lipoic acid on adenosine monophosphate- activated protein kinase activity in obesity induced by ovariectomy in rats

Menopause

Volumn 18, Issue 9, 2011, Pages 1010-1017

  Cheng, Pao Yun ^a   Lee, Yen Mei ^b   Yen, Mao Hsiung ^b   Peng, Jia Chi ^b   Lam, Kwok Keung ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b National Defense Medical Center   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Catholic Mercy Hospital Hsinchu   (Taiwan)

Author keywords

Adenosine monophosphate activated protein kinase; Adipose tissue; Hypothalamus; Ovariectomy; Lipoic acid

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; ADIPONECTIN; LEPTIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; FOOD INTAKE; HYPOTHALAMUS; NONHUMAN; OBESITY; OVARIECTOMY; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; WHITE ADIPOSE TISSUE;

EID: 85027938080     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31820db576     Document Type: Article

References (42)

1. Kahn BB, Alquier T, Carling D, Hardie DG. AMPK-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005;1:15-25. (Pubitemid 43960587)
2. Xue B, Kahn BB. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 2006;574:73-83. (Pubitemid 43905798)
3. Minokoshi Y, Alquier T, Furukawa N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004;428:569-574. (Pubitemid 38480541)
4. Packer L, Witt EH, Tritschler HJ. Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-250.
5. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of >-lipoic acid. Hormones (Athens) 2006;5:251-258.
6. Holmquist L, Stuchbury G, Berbaum K, et al. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007;113:154-164. (Pubitemid 44969927)
7. Kim MS, Park JY, Namkoong C, et al. Anti-obesity effects of >-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004;10:727-733. (Pubitemid 38937638)
8. Lee Y, Naseem RH, Park BH, et al. >-Lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice. Biochem Biophys Res Commun 2006;344:446-452.
9. Kim MS, Lee KU. Role of hypothalamic 5¶-AMPYactivated protein kinase in the regulation of food intake and energy homeostasis. J Mol Med 2005;83:514-520.
10. Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002;81:603-611. (Pubitemid 34827870)
11. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411. (Pubitemid 36724404)
12. Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecol Endocrinol 2005;20:227-235. (Pubitemid 40862910)
13. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197-216. (Pubitemid 39423001)
14. Wade GN, Gray JM. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol Behav 1979;22:583-593. (Pubitemid 9169176)
15. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18.
16. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333. (Pubitemid 34761611)
17. Tsai YC, Lee YM, Lam KK, Wu YC, Yen MH, Cheng PY. The role of hypothalamic AMP-activated protein kinase in the ovariectomy-induced obesity in rats. Menopause 2010;17:1194-1200.
18. Cheng PY, Lee YM, Law KK, Lin CW, Yen MH. The involvement of AMP-activated protein kinases in the anti-inflammatory effect of nicotine in vivo and in vitro. Biochem Pharmacol 2007;74:1758-1765.
19. Hardie DG. Regulation of fatty acid synthesis via phosphorylation of acetyl-CoA carboxylase. Prog Lipid Res 1989;28:117-146.
20. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003;9:756-761. (Pubitemid 36749226)
21. Hardie DG, Carling D. The AMP-activated protein kinaseVfuel gauge of the mammalian cell? Eur J Biochem 1997;246:259-273. (Pubitemid 27232500)
22. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999;276:E1-E18. (Pubitemid 29065588)
23. Loftus TM, Jaworsky DE, Frehywot GL, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000;288:2379-2381. (Pubitemid 30448165)
24. Liu Y, Wan Q, Guan Q, Gao L, Zhao J. High-fat diet feeding impairs both the expression and activity of AMPK> in rats' skeletal muscle. Biochem Biophys Res Commun 2006;339:701-707. (Pubitemid 41739724)
25. Unger RH. The hyperleptinemia of obesity-regulator of caloric surpluses. Cell 2004;117:145-146.
26. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770. (Pubitemid 28485436)
27. Rahmouni K, Haynes WG. Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins. Bioessays 2001;23:1095-1099.
28. Muoio DM, Dohm GL, Fiedorek FT Jr, Tapscott EB, Coleman RA. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997; 46:1360-1363. (Pubitemid 27315287)
29. Steinberg GR, Bonen A, Dyck DJ. Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats. Am J Physiol 2002;282:E593-E600. (Pubitemid 34654775)
30. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, doseescalation trial. JAMA 1999;282:1568-1575. (Pubitemid 29504050)
31. Van Heek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Investig 1997;99:385-390. (Pubitemid 27414794)
32. Huong DT, Ide T. Dietary lipoic acidYdependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats. Br J Nutr 2008; 100:79-87.
33. Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003;52:268-276. (Pubitemid 36173178)
34. Im JA, Lee JW, Lee HR, Lee DC. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Maturitas 2006;54:65-71.
35. Kadowaki T, Yamauchi T, Kubota N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 2008;582:74-80. (Pubitemid 50012818)
36. Kubota N, Yano W, Kubota T, et al. Adiponectin stimulates AMPactivated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007;6:55-68. (Pubitemid 47007437)
37. Medina-Gomez G, Vidal-Puig A. Gateway to the metabolic syndrome. Nat Med 2005;11:602-603. (Pubitemid 40868299)
38. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289-295. (Pubitemid 44435142)
39. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332: 621-628.
40. de Groot LC, van Es AJ, van Raaij JM, Vogt JE, Hautvast JG. Adaptation of energy metabolism of overweight women to alternating and continuous low energy intake. Am J Clin Nutr 1989;50: 1314-1323. (Pubitemid 20013313)
41. Redman LM, Heilbronn LK, Martin CK, et al. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One 2009;4:e4377.
42. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001;25: 1680-1688. (Pubitemid 33052080)